Jasper Therapeutics Inc. (JSPR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jasper Therapeutics Inc.

    NASDAQ: JSPR · Real-Time Price · USD
    2.49
    0.07 (2.89%)
    At close: Oct 03, 2025, 3:59 PM
    2.53
    1.61%
    Pre-market: Oct 06, 2025, 06:16 AM EDT

    Jasper Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.38 -1.28 -0.47 -2.92
    PEG Ratio
    		 0.21 0.03 0.01 -0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 5.06 1.05 0.49 1.29
    P/FCF Ratio
    		 -4.94 -1.57 -0.38 -2.48
    P/OCF Ratio
    		 -4.98 -1.58 -0.38 -2.65
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.03 0.04 0.10 0.04
    Quick Ratio
    		 4.98 7.19 5.91 10.95
    Current Ratio
    		 4.98 7.19 5.91 10.95
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -1.16 -0.82 -1.05 -0.44
    Return on Assets
    		 -0.89 -0.68 -0.78 -0.33
    Return on Invested Capital
    		 -1.16 -0.8 -1.19 -0.41
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist